InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Points Jeffrey S., Chief Financial Officer. Director active across 1 companies, notably Cardiovascular Systems Inc. Cumulatively, 13 filings have been published. Total volume traded: €161k. The latest transaction was disclosed on 20 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€41,1163,000 shares@ €13.705212.2% of flow
Common Stock
SEC:0001437749-22-013312:0·
Ideal exit: 14 Feb 2023 (T+270)
€31,8102,000 shares@ €15.90521.5% of flow
Common Stock
SEC:0001437749-22-002876·
Ideal exit: 5 Nov 2022 (T+270)
€31,8102,000 shares@ €15.9059.4% of flow
Common Stock
SEC:0001437749-22-002876:0·
Ideal exit: 5 Nov 2022 (T+270)
€23,413778 shares@ €30.094215.8% of flow
Common Stock
SEC:0000914190-21-000314·
€23,413778 shares@ €30.09426.9% of flow
Common Stock
SEC:0000914190-21-000314:0·
04,714 shares0
Common Stock
SEC:0000914190-21-000296·
04,714 shares0
Common Stock
SEC:0000914190-21-000296:0·
€64,6022,102 shares@ €30.733843.7% of flow
Common Stock
SEC:0000914190-21-000274·
€64,6022,102 shares@ €30.733819.2% of flow
Common Stock
SEC:0000914190-21-000274:0·
0475 shares0
Common Stock
SEC:0000914190-21-000236·
0475 shares0
Common Stock
SEC:0000914190-21-000236:0·
€28,1691,000 shares@ €28.169219.0% of flow
Common Stock
SEC:0000914190-21-000141·
Ideal exit: 4 Feb 2022 (T+270)
€28,1691,000 shares@ €28.16928.4% of flow
Common Stock
SEC:0000914190-21-000141:0·
Ideal exit: 4 Feb 2022 (T+270)
13 of 13 declarations
About Points Jeffrey S.
Jeffrey S. Points serves as Chief Financial Officer at Cardiovascular Systems Inc. He is responsible for financial management and strategy within the company. His role requires expertise in finance and business management. Through his experience, he contributes to the growth and profitability of Cardiovascular Systems.
